Renovaro Biosciences Inc. (RENB)
NASDAQ: RENB
· Real-Time Price · USD
0.32
-0.01 (-3.82%)
At close: May 16, 2025, 3:59 PM
0.32
-2.08%
After-hours: May 16, 2025, 05:42 PM EDT
-3.82% (1D)
| Bid | 0.32 |
| Market Cap | 52.32M |
| Revenue (ttm) | 181.45K |
| Net Income (ttm) | -67.01M |
| EPS (ttm) | -0.95 |
| PE Ratio (ttm) | -0.34 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.35 |
| Volume | 1,099,003 |
| Avg. Volume (20D) | 1,466,972 |
| Open | 0.33 |
| Previous Close | 0.33 |
| Day's Range | 0.31 - 0.36 |
| 52-Week Range | 0.28 - 2.34 |
| Beta | 0.61 |
About RENB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RENB
Website n/a
1 month ago
-16.49%
Renovaro and Predictive Oncology shares are tradin...
Unlock content with
Pro Subscription
2 months ago
+53.95%
Renovaro shares are trading higher after the company announced a merger agreement with BioSymetrics to advance AI-driven biomarket discovery and precision medicine.
